Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C tablets plus targeted therapy in advanced renal cell carcinoma
ChiCTR2000034678Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ascorbic acid in renal cell carcinoma (RCC) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Disease progression-free survival. Started Jul 2020; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on ChiCTR2000034678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034678.